Published in Ann Thorac Surg on June 01, 1987
Surgical treatment of postinfarction rupture of the interventricular septum. Tex Heart Inst J (1991) 0.82
Transatrial closure of postinfarction ventricular septal defect. Tex Heart Inst J (1992) 0.75
Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg (1984) 2.07
Tranexamic acid significantly reduces blood loss associated with coronary revascularization. Ann Thorac Surg (1995) 1.44
Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation (1999) 1.43
Postischemic deterioration of sarcoplasmic reticulum: warm versus cold blood cardioplegia. Ann Thorac Surg (1993) 1.39
Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ Res (1990) 1.39
Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol (2001) 1.29
Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun (1987) 1.29
Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res (1999) 1.28
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
Mediastinitis following open-heart surgery. Review of two years' experience. Arch Surg (1973) 1.19
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Postpneumonectomy esophageal fistula: successful one-stage repair. J Thorac Cardiovasc Surg (1970) 1.16
Esophagogastrostomy. Analysis of 55 cases. J Thorac Cardiovasc Surg (1975) 1.15
Tricuspid regurgitation. A comparison of nonoperative management, tricuspid annuloplasty, and tricuspid valve replacement. J Thorac Cardiovasc Surg (1976) 1.15
Myocardial protection with red wine extract. J Cardiovasc Pharmacol (2000) 1.14
The long-term influence of coronary bypass grafts on myocardial infarction and survival. Ann Surg (1974) 1.13
Malignant fibrous histiocytoma of the mediastinum and lung: a report of three cases. J Thorac Cardiovasc Surg (1982) 1.13
Epicardial activation of the intact human heart without conduction defect. Circulation (1979) 1.13
Aneurysm of aberrant right subclavian artery. Rare cause of superior mediastinal tumor. N Y State J Med (1973) 1.10
Thoracic aortic dissection following cannulation for perfusion. Ann Thorac Surg (1974) 1.10
Fast-track recovery of the coronary bypass patient. Ann Thorac Surg (1994) 1.10
Is there a relationship between systemic perfusion temperature during coronary artery bypass grafting and extent of intraoperative ischemic central nervous system injury? J Thorac Cardiovasc Surg (2000) 1.08
Thoracotomy in patients over age seventy years: ten-year experience. J Thorac Cardiovasc Surg (1981) 1.06
Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res (1993) 1.05
Phrenic nerve paresis associated with the use of iced slush and the cooling jacket for topical hypothermia. J Thorac Cardiovasc Surg (1985) 1.02
Surgical implications in malignant cardiac disease. Ann Thorac Surg (1983) 1.02
A prospective study of sternal wound complications. Ann Thorac Surg (1984) 1.00
Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation (1997) 1.00
Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol (1986) 0.98
Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg (2000) 0.97
Computed tomography for evaluation of mediastinal lymph nodes in lung cancer: correlation with surgical staging. Ann Thorac Surg (1984) 0.95
Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res (1995) 0.95
The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg (1999) 0.95
Oxygen free radical signaling in ischemic preconditioning. Ann N Y Acad Sci (1999) 0.95
The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res (1996) 0.94
Experience with open mitral commissurotomy in 100 consecutive patients. Surgery (1974) 0.94
Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence. Ann Surg (1973) 0.94
Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation (1993) 0.92
Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol (1995) 0.91
Tumors of the heart: surgical considerations. J Cardiovasc Surg (Torino) (1984) 0.91
L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg (1995) 0.91
Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation (1996) 0.90
Complications of ventriculoatrial shunting for hydrocephalus requiring cardiac operation. Ann Thorac Surg (1969) 0.90
Coronary artery bypass with freeze-preserved saphenous vein allografts. J Thorac Cardiovasc Surg (1976) 0.90
Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection. Ann N Y Acad Sci (1998) 0.89
Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation (2000) 0.89
Blood conservation for myocardial revascularization. Is it cost effective? J Thorac Cardiovasc Surg (1987) 0.89
Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures. J Thorac Cardiovasc Surg (1983) 0.89
Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol (1986) 0.88
Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem (1996) 0.88
Use of extrafascially harvested radial artery for coronary artery revascularization: technical considerations. J Card Surg (2000) 0.88
Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem (1998) 0.88
Safety of prolonged ischemic arrest using hypothermic cardioplegia. J Thorac Cardiovasc Surg (1980) 0.88
Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation (2000) 0.88
Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. J Mol Cell Cardiol (1986) 0.87
Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg (1995) 0.87
Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol (1991) 0.87
Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation (1993) 0.87
Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr (1993) 0.86
Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther (1993) 0.86
Traumatic ventricular septal defect following closed-chest massage: a new approach to closure. Ann Thorac Surg (1984) 0.86
Effects of free radicals on the fluidity of myocardial membranes. Free Radic Res Commun (1989) 0.86
Nonthrombogenic aortic and vena caval bypass using heparin-coated tubes. Am J Surg (1974) 0.85
Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass. Circulation (1995) 0.85
Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther (1998) 0.85
Mucoepidermoid carcinoma of the trachea and bronchus: the case for conservative resection. Ann Thorac Surg (1980) 0.85
Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. J Thorac Cardiovasc Surg (1986) 0.84
Steroid-induced myocardial preservation is associated with decreased cell membrane microviscosity. Circulation (1989) 0.84
Retrograde continuous warm blood cardioplegia. Ann Thorac Surg (1991) 0.84
Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther (1995) 0.84